Nadia Galindo-Cabello

Mrs. Nadia Galindo-Cabello

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NGNadia Galindo-Cabello
Nadia Galindo-Cabello
ECEstefanía Caballano-Infantes
Estefanía Caballano-Infantes
GBGregorio Benites-Narcizo
Gregorio Benites-Narcizo
Salvador Pastor-IdoateSalvador Pastor-Idoate
Salvador Pastor-Idoate
Francisco J. Diaz CorralesFrancisco J. Diaz Corrales
Francisco J. Diaz Corrales
Ricardo Usategui-MartínRicardo Usategui-Martín
Ricardo Usategui-Martín
Retinal degenerative diseases (RDDs) comprise diverse genetic and phenotypic conditions that cause progressive retinal dysfunction and cell loss, leading to vision impairment or blindness. Most RDDs lack appropriate animal models for their study, which affects understanding their disease mechanisms and delays the progress of new treatment development. Recent advances in stem cell engineering, omics, and organoid technology are facilitating research into diseases for which there are no previously existing models. The development of retinal organoids produced from human stem cells has impacted the study of retinal development as well as the development of in vitro models of diseases, opening possibilities for applications in regenerative medicine, drug discovery, and precision medicine. In this review, we recapitulate research in the retinal organoid models for RDD, mentioning some of the main pathways underlying retinal neurodegeneration that can be studied in these new models, as well as their limitations and future challenges in this rapidly advancing field.

1 July 2025 in Metabolites
Verified
Journal Article
Open access
PDF file
Pablo Redruello-GuerreroPablo Redruello-Guerrero
Pablo Redruello-Guerrero
MGMaría Gómez-Tomás
María Gómez-Tomás
TSTomas Rechi Sierra
Tomas Rechi Sierra
LSLaura Molinero Sicilia
Laura Molinero Sicilia
NGNadia Galindo-Cabello
Nadia Galindo-Cabello
Salvador Pastor-IdoateSalvador Pastor-Idoate
Salvador Pastor-Idoate
Retinal detachment (RD) is a serious clinical condition that significantly impacts patients’ quality of life. Its management involves considering several clinical factors that may affect the therapeutic approach. Inflammatory complications can affect visual recovery, long-term outcomes, and prognosis. Understanding the underlying inflammatory mechanisms is key to improving personalized medicine and optimizing therapeutic approaches to management. This review comprehensively searched scientific databases (Medline, Web of Science, and Scopus), considering clinical and experimental studies published between 1999 and 2025. Specific MeSH terms and predefined inclusion and exclusion criteria were used to select the most relevant papers. A total of 140 studies were analyzed. The findings were analyzed qualitatively and illustrated with images from clinical practice. Several studies have demonstrated the critical role of cytokines in retinal inflammation, highlighting their importance in regulating the immune response following RD. In addition, oxidative stress, apoptotic mechanisms, and glia activation, particularly Müller cells and microglia, have been identified as crucial elements in the progression of retinal damage. In this sense, inflammation poses significant clinical challenges that require more effective therapeutic strategies. In conclusion, this review differs from previous literature by emphasizing the translational implications of inflammatory mechanisms in RD and by comparing experimental and clinical data. The management of RD should consider not only surgical aspects, but also modulation of the inflammatory response to improve visual outcomes and prevent long-term complications.

Verified
Journal Article
Open access
PDF file
Ricardo Usategui-MartínRicardo Usategui-Martín
Ricardo Usategui-Martín
NGNadia Galindo-Cabello
Nadia Galindo-Cabello
Salvador Pastor-IdoateSalvador Pastor-Idoate
Salvador Pastor-Idoate
JFJosé María Fernández-Gómez
José María Fernández-Gómez
ARAlvaro del Real
Alvaro del Real
JPJose-Luis Pérez-Castrillón
Jose-Luis Pérez-Castrillón
Metabolic bone diseases cover a broad spectrum of disorders that share alterations in bone metabolism that lead to a defective skeleton, which is associated with increasing morbidity, disability, and mortality. There is a close connection between the etiology of metabolic bone diseases and genetic factors, with TP53 being one of the genes associated therewith. The single nucleotide polymorphism (SNP) Arg72Pro of TP53 is a genetic factor associated with several pathologies, including cancer, stroke, and osteoporosis. Here, we aim to analyze the influence of the TP53 Arg72Pro SNP on bone mass in humanized Tp53 Arg72Pro knock-in mice. This work reports on the influence of the TP53 Arg72Pro polymorphism in bone microarchitecture, OPG expression, and apoptosis bone status. The results show that the proline variant of the TP53 Arg72Pro polymorphism (Pro72-p53) is associated with deteriorated bone tissue, lower OPG/RANK ratio, and lower apoptosis in bone tissue. In conclusion, the TP53 Arg72Pro polymorphism modulates bone microarchitecture and may be a genetic biomarker that can be used to identify individuals with an increased risk of suffering metabolic bone alterations.

29 January 2026 in Ophthalmologica
Verified
Journal Article
Closed access
TRTomás Rechi-Sierra
Tomás Rechi-Sierra
RLRosa Lomelino-Pinheiro
Rosa Lomelino-Pinheiro
EJElisa Julião-Campos
Elisa Julião-Campos
CNCarlos Marques Neves
Carlos Marques Neves
Pablo Redruello-GuerreroPablo Redruello-Guerrero
Pablo Redruello-Guerrero
Salvador Pastor-IdoateSalvador Pastor-Idoate
Salvador Pastor-Idoate
Introduction: This study aimed to characterize the inflammatory cytokine profile within silicone oil-associated fluid (SOAF) from eyes with complex rhegmatogenous retinal detachment (RRD) treated with silicone oil (SO) tamponade, comparing groups according to tamponade duration. Additionally, we aimed to assess in vitro the emulsification stability of SO in the presence of biological surfactant agents. Methods: This prospective multicenter study included 65 patients with complex RRD who underwent pars plana vitrectomy (PPV) with SO tamponade, divided into two groups according to tamponade duration (<6 months vs ≥6 months), and 30 control eyes that underwent PPV for epiretinal membrane or full-thickness macular hole without SO. SOAF and undiluted vitreous samples were collected and analyzed for cytokine levels (IL-1α, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17, IP-10/CXCL10, IFNγ, TNFα, TGFβ1-3, and MCP-1) using multiplex bead-based immunoassays and ELISA. In vitro emulsification assays were performed using SOs of different viscosities and various biological surfactants. Results: The inflammatory composite score (mean z-score of log10-transformed IL-6, IL-8, and MCP-1) was significantly higher in RRD eyes than in controls (0.78 [0.35–1.16] vs. −0.52 [−0.88 to 0.01]; p < 0.0001), with no significant differences between tamponade duration groups (0.82 [0.41–1.24] vs. 0.76 [0.33–1.13]; p = 0.62). In SOAF, IL-6, IL-8, MCP-1, and TGF-β isoforms were elevated compared with vitreous controls. In vitro assays showed that stable emulsions were formed in the presence of proteins (albumin or cell-culture supernatants), whereas lipidic or vitaminic surfactants produced unstable emulsions. Conclusion: Eyes with complex RRD exhibit a sustained pro-inflammatory and pro-fibrotic microenvironment within the perisilicone compartment, independent of tamponade duration. Proteins, particularly albumin, appear to act as key biological surfactants linking inflammation to SO emulsification. These findings highlight the need for targeted anti-inflammatory and anti-fibrotic strategies, as well as standardized tools for detecting subclinical emulsification.

20 November 2025 in Methods and Protocols
Verified
Journal Article
Open access
PDF file
LSLaura Molinero Sicilia
Laura Molinero Sicilia
AHAlejandro G. del Hierro
Alejandro G. del Hierro
NGNadia Galindo-Cabello
Nadia Galindo-Cabello
Pablo Redruello-GuerreroPablo Redruello-Guerrero
Pablo Redruello-Guerrero
Salvador Pastor-IdoateSalvador Pastor-Idoate
Salvador Pastor-Idoate
DBDavid Bernardo
David Bernardo
Retinal detachment (RD) disrupts the eye’s immune-privileged status, causing a local inflammatory response that contributes to adverse clinical outcomes, including proliferative vitreoretinopathy and suboptimal visual recovery. Comprehensive profiling of intraocular immune cells will offer mechanistic insights and support the development of personalized immunomodulatory strategies. Here, we describe a robust and standardized protocol for the collection and high-dimensional analysis of the intraocular immune infiltrate from patients undergoing RD surgery, using state-of-the-art spectral cytometry. Vitreous and retinal tissue samples were obtained during standard surgical procedures, without the need for additional invasive interventions. Our approach integrates two complementary protocols: one that enables selective isolation of immune cells by sorting for CD45+ populations, and a second one that applies a 39-color spectral cytometry panel to profile the general landscape of immune subpopulations. The panel can identify up to 62 distinct viable immune subsets per sample, along with their functional status, as it includes expression of 13 functional markers. Hence, we hereby detail sample preparation, staining, and acquisition workflow, as well as the gating strategy and essential steps necessary for reproducible immunophenotyping. Our protocol, which enables high-dimensional immune profiling from minimal biological material, provides a valuable platform for studying ocular inflammation in RD and other retinal diseases.

10 October 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
Ricardo Usategui-MartínRicardo Usategui-Martín
Ricardo Usategui-Martín
NGNadia Galindo-Cabello
Nadia Galindo-Cabello
Salvador Pastor-IdoateSalvador Pastor-Idoate
Salvador Pastor-Idoate
JFJosé María Fernandez-Gómez
José María Fernandez-Gómez
ARAlvaro del Real
Alvaro del Real
JPJose-Luis Pérez-Castrillón
Jose-Luis Pérez-Castrillón
Metabolic bone diseases cover a broad spectrum of disorders that share alterations of bone metabolism leading to a defective skeleton, associated with increasing morbidity, disability, and mortality. There is a close connection between the etiology of metabolic bone diseases and genetic factors, being TP53 one of the genes associated therewith. The single nucleotide polymorphism (SNP) Arg72Pro of TP53 is a genetic factor associated with several pathologies, including cancer, stroke and osteoporosis. Here, we aim to analyze the influence of the TP53 Arg72Pro SNP on bone mass in the humanized Tp53 Arg72Pro knock-in mice. This work reported on the influence of TP53 Arg72Pro polymorphism in bone microarchitecture, OPG gene expression and apoptosis bone status. The results showed that the proline variant of TP53 Arg72Pro polymorphism (Pro72-p53) was associated with deteriorated bone tissue, lower OPG/RANK ratio and lower apoptosis in bone tissue. In conclusion, the TP53 Arg72Pro polymorphism modulates bone microarchitecture and may be a genetic biomarker to identify individuals with an increased risk of suffering metabolic bone alterations